Comparative Analysis of High-Dose Dual Therapies in First-Line <i>Helicobacter pylori</i> Eradication: An Inverse Probability of Treatment-Weighted Multicenter Study
HDDT, particularly VA-14, is a competitive first-line option for H. pylori eradication. High BSA and low adherence were risk factors for eradication failure but varied across regimens, highlighting the necessity of personalized adjustment.
Authors
- Hongyu Zhao (ORCID: https://orcid.org/0000-0002-8999-3285)
- Baobao Wang (ORCID: https://orcid.org/0000-0001-5615-7910)
- Yanqing LI
- Xiaohui Song (ORCID: https://orcid.org/0009-0006-2004-2090)
- Yuting Guo (ORCID: https://orcid.org/0009-0006-8860-5005)
- Long Xu (ORCID: https://orcid.org/0000-0002-6823-6330)
- Yueyue Li
- Xiuli Zuo
- Wenrong Geng
- Yanbing Ding
- Kunping Ju
- Miao Duan
- Xiaowei Li
- Yingying Han
- Hong Lu
- Bengang Zhou
- Peiyuan Li
- Qingzhou Kong
Institutions
- Shandong University of Traditional Chinese Medicine (CN)
- Zaozhuang Municipal Hospital (CN)
- Binzhou People's Hospital (CN)
- Northern Jiangsu People's Hospital (CN)
- State Key Laboratory of Oncogene and Related Genes (CN)
- Jimo District Qingdao Hospital of Traditional Chinese Medicine (CN)
- Affiliated Hospital of Shandong University of Traditional Chinese Medicine (CN)
- Tongji Hospital (CN)
- Qilu Hospital of Shandong University (CN)
- First Affiliated Hospital Zhejiang University (CN)
- Huazhong University of Science and Technology (CN)
- Yangzhou University (CN)
Publication Details
- Journal
- The Journal of Infectious Diseases
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1093/infdis/jiag059
- Citations
- 1
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 39.15